[go: up one dir, main page]

EP1144640A3 - Acides nucleiques et proteines de streptococcus pneumoniae - Google Patents

Acides nucleiques et proteines de streptococcus pneumoniae

Info

Publication number
EP1144640A3
EP1144640A3 EP99934990A EP99934990A EP1144640A3 EP 1144640 A3 EP1144640 A3 EP 1144640A3 EP 99934990 A EP99934990 A EP 99934990A EP 99934990 A EP99934990 A EP 99934990A EP 1144640 A3 EP1144640 A3 EP 1144640A3
Authority
EP
European Patent Office
Prior art keywords
proteins
nucleic acids
streptococcus pneumoniae
pneumoniae
streptococcus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99934990A
Other languages
German (de)
English (en)
Other versions
EP1144640A2 (fr
Inventor
Richard William Falla Le Page
Jeremy Mark Actinova Ltd. WELLS
Sean Bosco Hanniffy
Philip Michael CBVT Dis. Immun.Microbio HANSBRO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Technics Ltd
Original Assignee
Microbial Technics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9816336.3A external-priority patent/GB9816336D0/en
Application filed by Microbial Technics Ltd filed Critical Microbial Technics Ltd
Priority to EP05019268A priority Critical patent/EP1624064A3/fr
Priority to EP07000680A priority patent/EP1801218A3/fr
Publication of EP1144640A2 publication Critical patent/EP1144640A2/fr
Publication of EP1144640A3 publication Critical patent/EP1144640A3/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP99934990A 1998-07-27 1999-07-27 Acides nucleiques et proteines de streptococcus pneumoniae Withdrawn EP1144640A3 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP05019268A EP1624064A3 (fr) 1998-07-27 1999-07-27 Acides nucléiques et protéines de streptococcus pneumoniae
EP07000680A EP1801218A3 (fr) 1998-07-27 1999-07-27 Acides nucléiques et protéines de la pneumonie à streptocoques

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9816336 1998-07-27
GBGB9816336.3A GB9816336D0 (en) 1998-07-27 1998-07-27 Proteins
US12532999P 1999-03-19 1999-03-19
US125329P 1999-03-19
PCT/GB1999/002452 WO2000006738A2 (fr) 1998-07-27 1999-07-27 Acides nucleiques et proteines de streptococcus pneumoniae

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP05019268A Division EP1624064A3 (fr) 1998-07-27 1999-07-27 Acides nucléiques et protéines de streptococcus pneumoniae

Publications (2)

Publication Number Publication Date
EP1144640A2 EP1144640A2 (fr) 2001-10-17
EP1144640A3 true EP1144640A3 (fr) 2001-11-28

Family

ID=26314124

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99934990A Withdrawn EP1144640A3 (fr) 1998-07-27 1999-07-27 Acides nucleiques et proteines de streptococcus pneumoniae

Country Status (4)

Country Link
EP (1) EP1144640A3 (fr)
JP (2) JP2002521058A (fr)
CN (1) CN1318103A (fr)
WO (1) WO2000006738A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800744B1 (en) 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
DK1098980T3 (da) 1998-07-22 2014-09-29 Stichting Dienst Landbouwkundi Streptococcus suis-vacciner og diagnostiske tests
CN100398653C (zh) * 1998-12-23 2008-07-02 益得生物医学公司 新颖的链球菌抗原
EP1950302B1 (fr) * 1998-12-23 2012-12-05 ID Biomedical Corporation of Quebec Nouveaux antigènes de streptocoque
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
US6887480B1 (en) 1999-06-10 2005-05-03 Medimmune, Inc. Streptococcus pneumoniae proteins and vaccines
ATE500843T1 (de) * 1999-06-10 2011-03-15 Medimmune Llc Streptococcus pneumoniae proteine und impfstoffe
DE10012370A1 (de) * 2000-03-14 2001-09-27 Chiron Behring Gmbh & Co Adjuvans für Vakzinen
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
EP1205552A1 (fr) * 2000-11-09 2002-05-15 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. Virulence de streptococci, avec ORFs de Streptococcus suis
GB0107658D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
GB0108079D0 (en) 2001-03-30 2001-05-23 Microbial Technics Ltd Protein
AU2002351623A1 (en) 2001-12-20 2003-07-09 Shire Biochem Inc. Streptococcus antigens
WO2004048575A2 (fr) * 2002-11-26 2004-06-10 Id Biomedical Corporation Polypeptides de streptococcus pneumoniae
EP1615950A2 (fr) * 2003-04-15 2006-01-18 Intercell AG Antigenes s-pneumoniae
JP5049264B2 (ja) * 2005-04-08 2012-10-17 ワイス・エルエルシー ｐＨ操作によるストレプトコッカス・ニューモニエ多糖からの混入物の分離
GB0714963D0 (en) * 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
DK2268618T3 (en) 2008-03-03 2015-08-17 Novartis Ag Compounds and compositions as TLR aktivitetsmodulatorer
CA2718473A1 (fr) 2008-03-17 2009-09-24 Intercell Ag Peptides luttant contre s. pneumoniae et compositions, methodes et utilisations associees
ATE523204T1 (de) 2009-02-16 2011-09-15 Karlsruher Inst Technologie Cd44v6-peptide als bakterielle infektionsinhibitoren
EP2440245B1 (fr) 2009-06-10 2017-12-06 GlaxoSmithKline Biologicals SA Vaccins contenant benzonaphtyridines
CA2803061A1 (fr) 2009-06-29 2011-01-20 Genocea Biosciences, Inc. Vaccins et compositions contre le streptococcus pneumoniae
TWI445708B (zh) 2009-09-02 2014-07-21 Irm Llc 作為ｔｌｒ活性調節劑之化合物及組合物
SG178954A1 (en) 2009-09-02 2012-04-27 Novartis Ag Immunogenic compositions including tlr activity modulators
AU2010293902A1 (en) 2009-09-10 2012-03-22 Novartis Ag Combination vaccines against respiratory tract diseases
WO2011057148A1 (fr) 2009-11-05 2011-05-12 Irm Llc Composés et compositions permettant de moduler l'activité des tlr-7
MX339146B (es) 2009-12-15 2016-05-13 Novartis Ag Suspension homogenea de compuestos inmunopotenciadores y usos de los mismos.
WO2011112906A2 (fr) 2010-03-12 2011-09-15 Children's Medical Center Corporation Nouveaux immunogènes et procédés pour la découverte et le dépistage de ceux-ci
EP2549990A1 (fr) 2010-03-23 2013-01-30 Irm Llc Composés (lipopeptides à base de cystéine) et compositions en tant qu'agonistes des tlr2 utilisés pour traiter des infections, inflammations, maladies respiratoires entre autres
WO2012072769A1 (fr) 2010-12-01 2012-06-07 Novartis Ag Epitopes rrgb de pneumocoque et combinaisons de variantes
SG10201600435UA (en) 2011-01-20 2016-02-26 Genocea Biosciences Inc Vaccines And Compositions Against Streptococcus Pneumoniae
EP2822586A1 (fr) 2012-03-07 2015-01-14 Novartis AG Formulations contenant un adjuvant d'antigènes de streptococcus pneumoniae
CN105188747A (zh) 2013-02-01 2015-12-23 葛兰素史密斯克莱生物公司 包含toll样受体激动剂的免疫组合物的皮内递送
ES2959258T3 (es) * 2013-02-07 2024-02-22 Childrens Medical Center Antígenos proteicos que proporcionan protección contra la colonización y/o la enfermedad neumocócicas
CN103834667B (zh) * 2013-12-31 2016-08-17 李越希 化学合成的肺炎链球菌PspA蛋白胞外区基因片段及其表达、应用
EP3752182B1 (fr) 2018-02-12 2024-05-15 Inimmune Corporation Ligands du récepteur de type toll
JP7535791B2 (ja) * 2018-09-12 2024-08-19 ザ チルドレンズ メディカル センター コーポレーション 肺炎球菌融合タンパク質ワクチン
WO2020056202A1 (fr) 2018-09-12 2020-03-19 Affinivax, Inc. Vaccins antipneumococciques multivalents
KR20230117105A (ko) 2020-11-04 2023-08-07 엘리고 바이오사이언스 큐티박테리움 아크네스 재조합 파지, 그의 제조 방법 및 용도
KR20240099160A (ko) 2021-09-09 2024-06-28 아피니백스, 인크. 다가 폐렴구균 백신

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928900A (en) * 1993-09-01 1999-07-27 The Rockefeller University Bacterial exported proteins and acellular vaccines based thereon
EP0907738A1 (fr) * 1996-04-02 1999-04-14 Smithkline Beecham Corporation Nouveaux composes
JP2000508178A (ja) * 1996-05-14 2000-07-04 スミスクライン・ビーチャム・コーポレイション 新規化合物
DE69739981D1 (de) * 1996-10-31 2010-10-14 Human Genome Sciences Inc Streptococcus pneumoniae-Antigene und Impfstoffe
US6071724A (en) * 1996-12-13 2000-06-06 Eli Lilly And Company Streptococcus pneumoniaegene sequence era
GB9700939D0 (en) * 1997-01-17 1997-03-05 Microbial Technics Limited Therapy

Also Published As

Publication number Publication date
CN1318103A (zh) 2001-10-17
WO2000006738A3 (fr) 2001-08-23
WO2000006738A2 (fr) 2000-02-10
JP2002521058A (ja) 2002-07-16
EP1144640A2 (fr) 2001-10-17
JP2008022856A (ja) 2008-02-07

Similar Documents

Publication Publication Date Title
EP1144640A3 (fr) Acides nucleiques et proteines de streptococcus pneumoniae
AU2002309130A1 (en) Streptococcus pneumoniae proteins and nucleic acids
AU2002214127A1 (en) Nucleic acids and proteins from streptococcus groups A and B
AU5793798A (en) Streptococcus pneumoniae dna sequences
WO1999046281A8 (fr) Nouveaux polypeptides et acides nucleiques les codant
AU2002214531A1 (en) Proteins and nucleic acids encoding same
AU6667998A (en) Nucleic acids encoding caspase-8h and caspase-8i
AU2486300A (en) Secreted proteins and nucleic acids encoding them
AU2001288390A1 (en) Proteins and nucleic acids encoding same
AU6280899A (en) Secreted proteins and nucleic acids encoding them
AU2710400A (en) Monocyte-derived nucleic acids and related compositions and methods
AU3511100A (en) Novel nucleic acids and polypeptides
AU6164099A (en) Hrpca 9 and hrpca 10 nucleic acids and polypeptides
AU1525499A (en) Ikap proteins, nucleic acids and methods
AU5377599A (en) Nucleic acids
AU7756100A (en) Interleukin-2 like protein and nucleic acids encoding same
AU2002211681A1 (en) Proteins and nucleic acids encoding same
AU1690200A (en) Novel protein and dna thereof
AU2059500A (en) Huhdgfh nucleic acids, polypeptides, methods and uses thereof
AU1837100A (en) Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof
AU5447999A (en) Novel protein and dna thereof
AU2017201090B2 (en) Nucleic acids and proteins from streptococcus groups A & B
AU2017201090A1 (en) Nucleic acids and proteins from streptococcus groups A & B
AU2381700A (en) Ndsp nucleic acids and polypeptides
AU2002313838A1 (en) Novel PRO866 polypeptides and nucleic acids encoding same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

17P Request for examination filed

Effective date: 20010227

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

XX Miscellaneous (additional remarks)

Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR.

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20050223

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050906